Evidence mapPaperPMID 41366709Full record

ArticleHuman genomics2025

Recurrent somatic copy number alterations in resected cerebral cavernous malformations.

Andrew K Ressler, Evon Debose-Scarlett, Amanda Fuenzalida, Rhonda Lightle, Shantel Weinsheimer, Marie E Faughnan, Edda Spiekerkoetter, Katharina Schimmel, Michael Lawton, Helen Kim and 2 more

Abstract read
In one paragraph

Article in Human genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Andrew K ResslerDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, USA. akr55@duke.edu.
Evon Debose-ScarlettDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, USA.
Amanda FuenzalidaDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, USA.
Rhonda LightleDepartment of Neurological Surgery, University of Chicago Pritzker School of Medicine, Chicago, USA.
Shantel WeinsheimerDepartment of Anesthesia and Perioperative Care, University of California, San Francisco School of Medicine, San Francisco, USA.
Marie E FaughnanDivision of Respirology, Department of Medicine, University of Toronto, Toronto, Canada.
Edda SpiekerkoetterDepartment of Medicine, Division of Pulmonary, Allergy and Critical Care, Stanford University, Stanford, USA.
Katharina SchimmelDepartment of Medicine, Division of Pulmonary, Allergy and Critical Care, Stanford University, Stanford, USA.
Michael LawtonBarrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA.
Helen KimDepartment of Anesthesia and Perioperative Care, University of California, San Francisco School of Medicine, San Francisco, USA.
Issam AwadDepartment of Neurological Surgery, University of Chicago Pritzker School of Medicine, Chicago, USA.
Douglas A MarchukDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, USA.

Funding

VCRC Administration UnitU54NS065705 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KIM, HELEN · 2009 to 2023
$20.8M
Somatic mutation(s) and cellular changes in CCM pathogenesisP01NS092521 · NINDS · DUKE UNIVERSITY · PI MARCHUK, DOUGLAS A. · 2015 to 2024
$12.9M
Understanding and targeting molecular and cellular events responsible for pulmonary arteriovenous malformation development, growth and regressionR01HL169787 · NHLBI · STANFORD UNIVERSITY · PI Edda Frauke Spiekerkoetter · 2023 to 2026
$2.8M
American Heart Association-American Stroke Association 25PRE1376869National Organization for Rare Diseases 32001NHLBI NIH HHS R01 HL169787NIH/NINDS 2P01-NS092521NINDS NIH HHS P01 NS092521NINDS NIH HHS U54 NS065705
6 · The paper itself

Abstract

Cerebral Cavernous Malformations (CCMs) are brain vascular lesions that occur in sporadic or inherited (autosomal dominant) forms. The malformations are driven by mutations in KRIT1, CCM2, PDCD10 or MAP3K3. Known oncogenic variants in PIK3CA accompany CCM-specific variants in lesions. While the primary genetic etiology of CCM lesions is relatively well understood, a subset of lesions does not yet have an identified molecular genetic etiology. Moreover, whether large genomic alterations occur somatically in CCM lesion tissue has been largely unexplored. In PIK3CA + cancers, large somatic copy number alterations ('CNAs') are frequent, with whole genome doubling and aneuploidy identified in most tumors. Such CNA events are known to be associated with course of disease and therapeutic response. In this study, using whole genome SNP-genotyping and Mosaic Chromosome Alteration (MoChA) analysis, we identify the presence of large (> 1 MB) somatic CNAs in CCMs, with specific enrichment of events in chromosome arms 16p,19p,17q, 20q. We also identify additional chromosome arm level events encompassing known CCM genes in a subset of lesions. Thus, we characterize a pattern of large genomic events that had remained hidden by the insensitivity of the molecular and analytical methods previously used. Finally, we propose that similar events may be found in other vascular malformations or PIK3CA overgrowth syndromes that have yet to be analyzed in this manner.

Indexed as

DNA Copy Number VariationsHemangioma, Cavernous, Central Nervous SystemAdultCarrier ProteinsClass I Phosphatidylinositol 3-KinasesFemaleHumansKRIT1 ProteinMaleMiddle AgedMutationPolymorphism, Single NucleotideProto-Oncogene ProteinsCarrier ProteinsCCM2 protein, humanClass I Phosphatidylinositol 3-KinasesKRIT1 ProteinKRIT1 protein, humanPIK3CA protein, humanProto-Oncogene Proteins

Identifiers

PMID41366709
PMCPMC12801689

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.